Elevated plasma matrix metalloproteinase-9 protein and its gene polymorphism in patients with community-acquired pneumonia

Clinical Chemistry and Laboratory Medicine

Volumn 50, Issue 3, 2012, Pages 449-454

  Chiang, Ting Yen ^a   Shyu, Ling Yuh ^a   Tsao, Thomas Chang Yao ^a   Chien, Ming Hsien ^b,c   Tsao, Shih Ming ^a,d   Lee, Yuan Ti ^a,d   Yang, Shun Fa ^a,d  

^a CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^d CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

community acquired pneumonia; gene polymorphism; metalloproteinase 9 (MMP 9)

Indexed keywords

GELATINASE B;

ADULT; ARTICLE; COMMUNITY ACQUIRED PNEUMONIA; CONTROLLED STUDY; DISEASE PREDISPOSITION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; GENOTYPE; HUMAN; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL COUNT; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM;

CASE-CONTROL STUDIES; COMMUNITY-ACQUIRED INFECTIONS; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LEUKOCYTE COUNT; MALE; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; NEUTROPHILS; PNEUMONIA; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84860435518     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/cclm.2011.805     Document Type: Article

References (26)

1. Kumar V, Abbas AK, Fausto N, Robbins S. Pathologic basis of disease, 8th ed. Philadelphia: Elsevier Saunders, 2009:710-1.
2. Tetley TD. New perspectives on basic mechanisms in lung disease. Proteinase imbalance: its role in lung disease. Thorax 1993;48:560-5.
3. Lukkarinen H, Hogmalm A, Lappalainen U, Bry K. Matrix metalloproteinase- 9 defi ciency worsens lung injury in a model of bronchopulmonary dysplasia. Am J Respir Cell Mol Biol 2009;41:59-68.
4. Atkinson JJ, Senior RM. Matrix metalloproteinase-9 in lung remodeling. Am J Respir Cell Mol Biol 2003;28:12-24. (Pubitemid 36017046)
5. Torii K, Iida K, Miyazaki Y, Saga S, Kondoh Y, Taniguchi H, et al. Higher concentrations of matrix metalloproteinases in bronchoalveolar lavage fl uid of patients with adult respiratory distress syndrome. Am J Respir Crit Care Med 1997;155:43-6. (Pubitemid 27053139)
6. Sepper R, Konttinen YT, Ding Y, Takagi M, Sorsa T. Human neutrophil collagenase (MMP-8), identifi ed in bronchiectasis BAL fl uid, correlates with severity of disease. Chest 1995;107:1641-7.
7. Choi KH, Lee HB, Jeong MY, Rhee YK, Chung MJ, Kwak YG, et al. The role of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in cryptogenic organizing pneumonia. Chest 2002;121:1478-85. (Pubitemid 34499659)
8. Segura-Valdez L, Pardo A, Gaxiola M, Uhal BD, Becerril C, Selman M. Upregulation of gelatinases a and b, collagenases 1 and 2, and increased parenchymal cell death in COPD. Chest 2000;117:684-94. (Pubitemid 30152206)
9. Bayramoglu A, Gunes HV, Metintas M, De g? irmenci I, Mutlu F, Alata s F. The association of MMP-9 enzyme activity, MMP-9 C1562T polymorphism, and MMP-2 and -9 and TIMP-1, -2, -3, and -4 gene expression in lung cancer. Genet Test Mol Biomarkers 2009;13:671-8.
10. Lee SH, Han SK, Shim YS, Yim JJ. Effect of matrix metalloproteinase- 9 -1562C/T gene polymorphism on manifestations of pulmonary tuberculosis. Tuberculosis (Edinb) 2009;89:68-70.
11. Hu Z, Huo X, Lu D, Qian J, Zhou J, Chen Y, et al. Functional polymorphisms of matrix metalloproteinase-9 are associated with risk of occurrence and metastasis of lung cancer. Clin Cancer Res 2005;11:5433-9. (Pubitemid 41060818)
12. Tesfaigzi Y, Myers OB, Stidley CA, Schwalm K, Picchi M, Crowell RE, et al. Genotypes in matrix metalloproteinase 9 are a risk factor for COPD. Int J Chron Obstruct Pulmon Dis 2006;1:267-78.
13. Nakashima K, Hirota T, Obara K, Shimizu M, Doi S, Fujita K, et al. A functional polymorphism in MMP-9 is associated with childhood atopic asthma. Biochem Biophys Res Commun 2006;344:300-7.
14. Nagase H, Woessner JF Jr. Matrix metalloproteinases. J Biol Chem 1999;274:21491-4.
15. Stetler-Stevenson WG. Dynamics of matrix turnover during pathologic remodeling of the extracellular matrix. Am J Pathol 1996;148:1345-50.
16. Yang SF, Chu SC, Chiang IC, Kuo WF, Chiou HL, Chou FP, et al. Excessive matrix metalloproteinase-9 in the plasma of community- acquired pneumonia. Clin Chim Acta 2005;352:209-15.
17. Zhang B, Ye S, Herrmann SM, Eriksson P, de Maat M, Evans A, et al. Functional polymorphism in the regulatory region of gelatinase B gene in relation to severity of coronary atherosclerosis. Circulation 1999;99:1788-94. (Pubitemid 29181405)
18. Ye S. Infl uence of matrix metalloproteinase genotype on cardiovascular disease susceptibility and outcome. Cardiovasc Res 2006;69:636-45. (Pubitemid 43139726)
19. Omachi TA, Eisner MD, Rames A, Markovtsova L, Blanc PD. Matrix metalloproteinase-9 predicts pulmonary status declines in 1-antitrypsin defi ciency. Respir Res 2011;12:35.
20. Bayramoglu A, Gunes HV, Metintas M, De g? irmenci I, Mutlu F, Alata s F. The association of MMP-9 enzyme activity, MMP-9 C1562T polymorphism, and MMP-2 and -9 and TIMP-1, -2, -3, and -4 gene expression in lung cancer. Genet Test Mol Biomarkers 2009;13:671-8.
21. Taghavi S, Krenn K, Jaksch P, Klepetko W, Aharinejad S. Bron choalveolar lavage matrix metalloproteases as a sensitive measure of bronchiolitis obliterans. Am J Transplant 2005;5:1548-52. (Pubitemid 40839451)
22. Zhang B, Henney A, Eriksson P, Hamsten A, Watkins H, Ye S. Genetic variation at the matrix metalloproteinase-9 locus on chromosome 20q12.2-13.1. Hum Genet 1999;105:418-23.
23. Meijer MJ, Mieremet-Ooms MA, Sier CF, van Hogezand RA, Lamers CB, Hommes DW, et al. Matrix metalloproteinases and their tissue inhibitors as prognostic indicators for diagnostic and surgical recurrence in Crohn's disease. Infl amm Bowel Dis 2009;15:84-92.
24. Ghaderian SM, Akbarzadeh Najar R, Tabatabaei Panah AS. Genetic polymorphisms and plasma levels of matrix metalloproteinases and their relationships with developing acute myocardial infarction. Coron Artery Dis 2010;21:330-5.
25. Hulkkonen J, Pertovaara M, Antonen J, Pasternack A, Hurme M, P ö ll ä nen P, et al. Matrix metalloproteinase-9 (MMP-9) gene polymorphism and MMP-9 plasma levels in primary Sjogren's syndrome. Rheumatology (Oxford) 2004;43:1476-9.
26. Ghaderian SM, Najar RA, Tabatabaei Panah AS, Rezaie G, Rezaei Farimani A, Beigi Harchegani A, et al. Matrix metalloproteinase: investigation from gene to protein as effective factor in myocardial infarction. J Thromb Thrombolysis 2010;30:404-11.